TorMagnus Pharmaceuticals Company

TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.


Investors

Total Funding: 500000.0
Headquarters: San Francisco, California, United States
Funding Status: Seed
Last Funding Type: Pre-Seed
Technology: ['BioTech & HealthTech']
Investor Type: contact@tormagnuspharma.com
Last Funding Date: 2023-04-05
Investors Number: 1.0
Founded Date: 2022-05-01
Industry: Medical BioTech